UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 259

Sortiert nach

Effects of changing criteria on improving interRAI assessment for elder abuse: analysis of a national dataset from Aotearoa New Zealand

BMJ open, 2024-07, Vol.14 (7), p.e081791

2024

Volltextzugriff (PDF)

Olfactory shifts linked to postpartum depression

Scientific reports, 2021-07, Vol.11 (1), p.14947-14947, Article 14947

2021

Volltextzugriff (PDF)

Pilot Randomized-Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment Resistant Depression

The American journal of geriatric psychiatry, 2017-11, Vol.25 (11), p.1199-1209

2017

Volltextzugriff (PDF)

Right frontal anxiolytic-sensitive EEG 'theta' rhythm in the stop-signal task is a theory-based anxiety disorder biomarker

Scientific reports, 2021-10, Vol.11 (1), p.19746-19746, Article 19746

2021

Volltextzugriff (PDF)

Ketamine as a new treatment for depression: a review of its efficacy and adverse effects

Australian & New Zealand Journal of Psychiatry, 2013-08, Vol.47 (8), p.710-727

2013

Volltextzugriff (PDF)

Multidisciplinary development of guidelines for ketamine treatment for treatment-resistant major depression disorder for use by adult specialist mental health services in New Zealand

BJPsych open, 2023-10, Vol.9 (6), p.e191-e191, Article e191

2023

Volltextzugriff (PDF)

Anti-anxiety drugs reduce conflict-specific “theta”—A possible human anxiety-specific biomarker

Journal of affective disorders, 2013-05, Vol.148 (1), p.104-111

2013

Volltextzugriff (PDF)

Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders

Therapeutic advances in psychopharmacology, 2021-12, Vol.11, p.20451253211056743-20451253211056743

2021

Volltextzugriff (PDF)

Right Frontal Theta: Is It a Response Biomarker for Ketamine’s Therapeutic Action in Anxiety Disorders?

Frontiers in neuroscience, 2022-07, Vol.16, p.900105-900105

2022

Volltextzugriff (PDF)

Ageing badly : indicators of old-age structure in Australia and New Zealand

Journal of primary health care, 2020-09, Vol.12 (3), p.272-276

2020

Volltextzugriff (PDF)

Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial

Trials, 2024-05, Vol.25 (1), p.336-336, Article 336

2024

Volltextzugriff (PDF)

Meta-Analysis of Relapse Prevention Antidepressant Trials in Depressive Disorders

Australian and New Zealand journal of psychiatry, 2010-08, Vol.44 (8), p.697-705

2010

Volltextzugriff (PDF)

Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the community

BMJ open, 2024-05, Vol.14 (5), p.e084844-e084844

2024

Volltextzugriff (PDF)

Is There Evidence for the Specificity of Closed-Loop Brain Training in the Treatment of Internalizing Disorders? A Systematic Review

Frontiers in neuroscience, 2022-03, Vol.16, p.821136-821136

2022

Volltextzugriff (PDF)

Infraslow closed-loop brain training for anxiety and depression (ISAD): a protocol for a randomized, double-blind, sham-controlled pilot trial in adult females with internalizing disorders

Trials, 2022-11, Vol.23 (1), p.949-949, Article 949

2022

Volltextzugriff (PDF)

Screaming behaviour in response to electroconvulsive treatment: psychogeriatric note on a patient with Alzheimer's disease

Psychogeriatrics, 2019-11, Vol.19 (6), p.626-627

2019

Volltextzugriff (PDF)

Unexpected Effect of Rifampin on the Pharmacokinetics of Linezolid: In Silico and In Vitro Approaches to Explain Its Mechanism

Journal of clinical pharmacology, 2011-02, Vol.51 (2), p.229-236

2011

Volltextzugriff (PDF)

A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical Study

Pharmaceutics, 2024-05, Vol.16 (5), p.602

2024

Volltextzugriff (PDF)

Possible mechanisms for treatment heterogeneity in clinical trials of adjunctive N‐acetylcysteine for bipolar depression

Bipolar disorders, 2022-03, Vol.24 (2), p.213-213

2022

Volltextzugriff (PDF)

Ketamine and psychotherapy for the treatment of psychiatric disorders: systematic review

BJPsych Open, 2023-05, Vol.9 (3), p.e79-e79, Article e79

2023

Volltextzugriff (PDF)

A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder

BMC medical research methodology, 2009-07, Vol.9 (1), p.55-55, Article 55

2009

Volltextzugriff (PDF)

Progesterone loading as a strategy for treating postpartum depression

Human psychopharmacology, 2020-05, Vol.35 (3), p.e2731-n/a

2020

Volltextzugriff (PDF)

Managing distance and covariate information with point-based clustering

BMC medical research methodology, 2016-09, Vol.16 (1), p.115-115, Article 115

2016

Volltextzugriff (PDF)

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study

Therapeutic advances in psychopharmacology, 2020, Vol.10, p.2045125320922474

2020

Volltextzugriff (PDF)

Dissociation after ketamine dosing: Is the CADSS fit for purpose?

Journal of affective disorders, 2019-02, Vol.244, p.239-240

2019

Volltextzugriff (PDF)

1 – 25 von 259

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(220)

Publikationsform

Sprache

Englisch
(259)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Effects of changing criteria on improving interRAI assessment for elder abuse: analysis of a national dataset from Aotearoa New Zealand

Olfactory shifts linked to postpartum depression

Pilot Randomized-Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment Resistant Depression

Right frontal anxiolytic-sensitive EEG 'theta' rhythm in the stop-signal task is a theory-based anxiety disorder biomarker

Ketamine as a new treatment for depression: a review of its efficacy and adverse effects

Multidisciplinary development of guidelines for ketamine treatment for treatment-resistant major depression disorder for use by adult specialist mental health services in New Zealand

Anti-anxiety drugs reduce conflict-specific “theta”—A possible human anxiety-specific biomarker

Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders

Right Frontal Theta: Is It a Response Biomarker for Ketamine’s Therapeutic Action in Anxiety Disorders?

Ageing badly : indicators of old-age structure in Australia and New Zealand

Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial

Meta-Analysis of Relapse Prevention Antidepressant Trials in Depressive Disorders

Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the community

Is There Evidence for the Specificity of Closed-Loop Brain Training in the Treatment of Internalizing Disorders? A Systematic Review

Infraslow closed-loop brain training for anxiety and depression (ISAD): a protocol for a randomized, double-blind, sham-controlled pilot trial in adult females with internalizing disorders

Screaming behaviour in response to electroconvulsive treatment: psychogeriatric note on a patient with Alzheimer's disease

Unexpected Effect of Rifampin on the Pharmacokinetics of Linezolid: In Silico and In Vitro Approaches to Explain Its Mechanism

A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical Study

Possible mechanisms for treatment heterogeneity in clinical trials of adjunctive N‐acetylcysteine for bipolar depression

Ketamine and psychotherapy for the treatment of psychiatric disorders: systematic review

A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder

Progesterone loading as a strategy for treating postpartum depression

Managing distance and covariate information with point-based clustering

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study

Dissociation after ketamine dosing: Is the CADSS fit for purpose?

Suchergebnisse filtern